Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Regulatory Status of Peptide Compounding in 2025
Research models where BPC-157 showed activity: Esophageal, gastric, and duodenal ulcers NSAID-induced small intestinal damage Colonic inflammation and ulceration Post-surgical anastomosis healing GI fistula closure In anastomosis research, BPC-157 improved healing in esophagogastric, jejunoileal, and colocolonic surgical connections
Who performs the treatment
Key Mechanisms One of BPC-157s key mechanisms is its ability to stimulate angiogenesis, the formation of new blood vessels, which supports nutrient delivery to damaged tissues and accelerates healing
Unfortunately, studies have shown that this vital peptide decreases significantly with age, slowing the bodys natural healing response
Heres how Id approach it: Start with half the standard dose (0.25mL weekly) Test MMA every 2 weeks to see how your cells are doing Bump up the dose by 0.1mL until MMA drops below 0.4 mol/L Thats your personal sweet spot the minimum dose that actually works When Your Labs Look Great But You Feel Terrible Sometimes your numbers look perfect on paper, but you still feel like garbage
